Hugo has proven expertise in the translation of protein biomarkers from concept to clinical value, including but not limited to target identification, selection and evaluation of tools & technologies (single analyte and multiplex immunoassay platforms), protein assay development (from prototyping to qualification, validation, and registration), clinical study design and execution, and market integration of assays or test concepts

He is a founder of Biomarkable and was a co-founder of ADx Neurosciences. He gained over 21 years IVD experience at Innogenetics (now Fujirebio). His experience covers various domains, including neurodegeneration, endocrinology (steroidogenesis, in-vitro fertilization, embryology), cardiovascular, infectious and autoimmune diseases.

He is a sought-after advisor in world-wide efforts to generate standard operating procedures for sample collection, storage and qualification of biomarker protein assays. He was a scientific advisor in several consortia including the Global Biomarker Standardization Consortium (ADNI), CPAD, and the Michael J Fox Foundation.

He has been the principal investigator in several multi-center projects, has authored or co-authored over 153 publications (H-index 58) and is listed as inventor on several patent applications.